Analytic Treatment Interruption (ATI) to Assess HIV Cure

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT02437526
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Analytic treatment interruption — OTHER

Study Details

This study is designed to determine if individual patients with HIV infection have been cured of the infection. To do this, antiretroviral therapy is discontinued under close medical supervision and the patient monitored over time for reactivation of infection.

Key Dates

First listed
May 7, 2015
Start date
May 31, 2015
Status verified
Jun 2026
Primary completion
May 31, 2035
Completion
May 31, 2035

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Treatment interruption
    Antiretroviral therapy will be discontinued under close laboratory monitoring and clinical supervision.

Primary Outcome Measure

Time to virologic rebound [ Time Frame: 38 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905-

Find similar trials in Rochester, MN

Nationwide
HIV trialsInfectious disease trials
By condition
HIV
By specialty
Infectious disease
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies